Answers are grounded in this paper and cite their sources.
Analysis indicates barriers limit access to fertility preservation among male cancer survivors, suggesting the need for improved oncology health care services.
Fertility preservation in males is acknowledging a developing recognition as essential in treatment planning for cancer. Many currently available cancer therapies including chemotherapy, radiation and novel immunotherapy can affect sperm production, testicular function and reproductive potential. Although sperm cryopreservation is the gold standard for patients, considering post pubertal patients, experimental approaches to preserve fertility including cryopreservation of testicular tissue as an option for prepubertal boys, are in development. Whilst we do not currently lack options, several barriers prevent patients from timely access to fertility counselling, primarily a lack of awareness at their diagnosis or timely education of specific services. Early access to fertility preservation services as part of oncology health care can improve reproductive outcome and enhance long-term quality of life for survivors. Changes in our current practices will require better communication, collaboration, and a focus on improving patient access to fertility preservation options.
No takes yet. Share an insight, caveat, or question.
Mansi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: